目前用于发现针对VEGFR和SIRT信号通路的新型抗癌剂的计算方法
Aleksandra Ilic1, Selma Zukic2, Slavica Oljacic1
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe, 450, 11221 Belgrade, Serbia.
Pharmaceutics
|February 27, 2026
概括
本综述探讨了用于癌症治疗的新型双抑制剂,重点关注血管内皮生长因子受体 (VEGFR) 和像sirtuins这样的表观遗传因素. 计算机辅助药物设计有助于开发这些有针对性的疗法以改善结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 遗传和表观遗传因素对癌症的发展和进展至关重要.
- 血管内皮生长因子受体 (VEGFR) 和表观遗传信号通路与癌症病理生理学有关.
- 赛尔图因是参与癌症发展的关键表观遗传因素.
研究的目的:
- 审查针对VEGFR和癌症发生过程中的表观遗传途径的新型治疗剂.
- 探索针对VEGFR和表观遗传因素的双重抑制剂在个性化癌症治疗中的潜力.
- 为了检查VEGFR,Sirtuin和双抑制剂的抗癌机制.
主要方法:
- 关于癌症分子机制的科学研究的文献综述.
- 分析计算机辅助药物设计 (CADD) 方法用于新型抑制剂开发.
- 探索涉及VEGFR和表观遗传因素的双重抑制的治疗策略.
主要成果:
- VEGFR和表观遗传途径对癌症的复杂变化有显著的贡献.
- 通过双重抑制剂同时向VEGFR和sirtuins,有可能实现个性化,更安全,更有效的癌症治疗.
- CADD促进了对双位抑制剂的新化学型的设计,加速了药物发现.
结论:
- 针对VEGFR和表观遗传因子的双重抑制剂代表了创新的癌症治疗的有希望的途径.
- CADD是设计新型表观遗传双抑制剂的宝贵工具.
- 了解这些抑制剂的抗癌机制是优化其治疗用途的关键.
相关概念视频
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
03:03mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
01:26Drug Discovery: Overview
12.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.3K
01:29Pharmacogenomics: Identification of New Drug Targets
53
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
53
01:41Non-Canonical Wnt Signaling Pathways
8.5K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.5K